Tapewire

NYSE · USD

COR

Cencora, Inc.

Export transactions ↓
Tapewire entity
2994
SEC CIK
0001140859
Parsed reports
801

Last 12 months

Inside the activity.

3 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202610
Jun 202620
Jul 202600
Aug 202601
Sep 202602
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 13, 2022 Filed Sep 15, 2022 20:24 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $142.40 $1,634,752.00
Disclosure

SEC source: 0001140859-22-000052 · wf-form4_166327348294030.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
September 13, 2022 Filed Sep 15, 2022 20:24 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001140859-22-000052 · wf-form4_166327348294030.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
September 02, 2022 Filed Sep 6, 2022 20:48 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 2,975 $0.00 $0.00
Disclosure

SEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · derivative · entry 3

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,975 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
September 02, 2022 Filed Sep 6, 2022 20:48 UTC
Donato Leslie EEVP & Chief Strategy Officer
Tax withholdingCommon Stock 1,108 $147.71 $163,662.68
Disclosure

SEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · nonDerivative · entry 2

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,675.967

Read SEC document
September 02, 2022 Filed Sep 6, 2022 20:48 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionCommon Stock 2,975 $0.00 $0.00
Disclosure

SEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,783.967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
August 30, 2022 Filed Sep 1, 2022 20:05 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 288 $146.80 $42,278.40
Disclosure

SEC source: 0001140859-22-000047 · wf-form4_166206274353504.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,526

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:14 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 11,480 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,880

Underlying: Common Stock · 11,480 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:14 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $144.25 $1,655,990.00
Disclosure

SEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
August 09, 2022 Filed Aug 11, 2022 20:14 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 20:02 UTC GrantCommon Stock 215 $145.93 $31,374.95
Disclosure

SEC source: 0001140859-22-000043 · wf-form4_165955690726132.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,199

F1 · shares: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer.

Read SEC document
July 12, 2022 Filed Jul 14, 2022 20:04 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 11,480 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,360

Underlying: Common Stock · 11,480 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
July 12, 2022 Filed Jul 14, 2022 20:04 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $142.35 $1,634,178.00
Disclosure

SEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
July 12, 2022 Filed Jul 14, 2022 20:04 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
July 01, 2022 Filed Jul 22, 2022 20:05 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 1,431 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · derivative · entry 4

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,864

Underlying: Common Stock · 1,431 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

F2 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

F2 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

Read SEC document
July 01, 2022 Filed Jul 22, 2022 20:05 UTC
Donato Leslie EEVP & Chief Strategy Officer
Tax withholdingCommon Stock 533 $143.14 $76,293.62
Disclosure

SEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 3

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,808.967

Read SEC document
July 01, 2022 Filed Jul 22, 2022 20:05 UTC
Donato Leslie EEVP & Chief Strategy Officer
Exercise / conversionCommon Stock 1,431 $0.00 $0.00
Disclosure

SEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 2

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,341.967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024.

Read SEC document
June 30, 2022 Filed Jul 14, 2022 20:12 UTC
Campbell Elizabeth SExecutive Vice President
GrantCommon Stock 68.603 $120.26 $8,250.06
Disclosure

SEC source: 0001140859-22-000034 · wf-form4_165782953000714.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,950.87

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Jul 14, 2022 20:07 UTC
Battaglia SilvanaExecutive Vice President
GrantCommon Stock 94.46 $120.26 $11,359.57
Disclosure

SEC source: 0001140859-22-000032 · wf-form4_165782921173442.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,371.9422

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Jul 22, 2022 20:05 UTC
Donato Leslie EEVP & Chief Strategy Officer
GrantCommon Stock 22.453 $120.26 $2,700.15
Disclosure

SEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 910.967

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:20 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 11,480 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001127602-22-017621 · form4.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,840

Underlying: Common Stock · 11,480 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:20 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $141.22 $1,621,205.60
Disclosure

SEC source: 0001127602-22-017621 · form4.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.

Read SEC document
June 14, 2022 Filed Jun 16, 2022 20:20 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001127602-22-017621 · form4.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:59 UTC SaleCommon Stock 6,000,000 $150.00 $900,000,000.00
Disclosure

SEC source: 0000899243-22-018024 · doc4.xml · nonDerivative · entry 1

Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner

Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 52,854,867

F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer.

F1 · ownership.direct: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer.

F2 · ownership.direct: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.

F3 · ownership.direct: As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4.

F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer.

F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.

F3 · ownership.nature: As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4.

Read SEC document
May 11, 2022 Filed May 13, 2022 20:04 UTC
Krikorian LazarusSVP & Chief Accounting Officer
SaleCommon Stock 4,895 $160.00 $783,200.00
Disclosure

SEC source: 0001127602-22-014391 · form4.xml · nonDerivative · entry 1

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,079

Read SEC document
May 10, 2022 Filed May 12, 2022 20:44 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 11,480 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001127602-22-014278 · form4.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,320

Underlying: Common Stock · 11,480 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
May 10, 2022 Filed May 12, 2022 20:44 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $159.47 $1,830,715.60
Disclosure

SEC source: 0001127602-22-014278 · form4.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
May 10, 2022 Filed May 12, 2022 20:44 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001127602-22-014278 · form4.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21.

Read SEC document
May 10, 2022 Filed May 12, 2022 20:40 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 6,654 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001127602-22-014275 · form4.xml · derivative · entry 4

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,218

Underlying: Common Stock · 6,654 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

F2 · balance_after: Balance reflects adjustment to previously overstated number of options.

Read SEC document
May 10, 2022 Filed May 12, 2022 20:40 UTC
Krikorian LazarusSVP & Chief Accounting Officer
SaleCommon Stock 105 $160.00 $16,800.00
Disclosure

SEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 3

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,974

Read SEC document
May 10, 2022 Filed May 12, 2022 20:40 UTC
Krikorian LazarusSVP & Chief Accounting Officer
SaleCommon Stock 6,654 $158.61 $1,055,390.94
Disclosure

SEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 2

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,079

Read SEC document
May 10, 2022 Filed May 12, 2022 20:40 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionCommon Stock 6,654 $89.58 $596,065.32
Disclosure

SEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 1

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 02, 2022 Filed May 2, 2022 21:19 UTC GrantCommon Stock 207 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-012866 · form4.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,984

F1 · shares: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer.

F1 · price: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer.

Read SEC document
April 12, 2022 Filed Apr 13, 2022 20:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 11,480 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001127602-22-011945 · form4.xml · derivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,800

Underlying: Common Stock · 11,480 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
April 12, 2022 Filed Apr 13, 2022 20:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 11,480 $162.11 $1,861,022.80
Disclosure

SEC source: 0001127602-22-011945 · form4.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,178

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.

Read SEC document
April 12, 2022 Filed Apr 13, 2022 20:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 11,480 $75.61 $868,002.80
Disclosure

SEC source: 0001127602-22-011945 · form4.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 20:00 UTC
Clark GinaExecutive Vice President
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 29,520 $0.00 Strike: $75.61 $0.00
Disclosure

SEC source: 0001127602-22-010646 · form4.xml · derivative · entry 3

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 29,520 shares

Expires 2023-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 20:00 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 43,704 $153.71 $6,717,741.84
Disclosure

SEC source: 0001127602-22-010646 · form4.xml · nonDerivative · entry 2

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,814

F1 · shares: The sale of common stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 2/16/2022.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 20:00 UTC
Clark GinaExecutive Vice President
Exercise / conversionCommon Stock 29,520 $75.61 $2,232,007.20
Disclosure

SEC source: 0001127602-22-010646 · form4.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale of common stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 2/16/2022.

Read SEC document
March 15, 2022 Filed Mar 16, 2022 19:59 UTC
Battaglia SilvanaExecutive Vice President
SaleCommon Stock 6,820 $149.96 $1,022,727.20
Disclosure

SEC source: 0001127602-22-009474 · form4.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277.4822

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:09 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009100 · form4.xml · derivative · entry 1

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:22 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001127602-22-009129 · form4.xml · derivative · entry 1

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:19 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009122 · form4.xml · derivative · entry 1

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:16 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009116 · form4.xml · derivative · entry 1

GREENBERG LON R · CIK 0001234234 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:13 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009111 · form4.xml · derivative · entry 1

McGee Henry Wadsworth III · CIK 0001307634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:12 UTC GrantRestricted Stock Units · Derivative 1,368 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009107 · form4.xml · derivative · entry 1

HENNEY JANE E MD · CIK 0001191522 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,368

Underlying: Common Stock · 1,368 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:06 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009092 · form4.xml · derivative · entry 1

LONG MICHAEL J · CIK 0001186373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant.

Read SEC document
March 10, 2022 Filed Mar 14, 2022 20:04 UTC GrantRestricted Stock Units · Derivative 1,197 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-009086 · form4.xml · derivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,197

Underlying: Common Stock · 1,197 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant.

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant.

F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant.

F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 20:41 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-008997 · form4.xml · derivative · entry 3

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,422

Underlying: Common Stock · 1,211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document
March 09, 2022 Filed Mar 11, 2022 20:41 UTC
Battaglia SilvanaExecutive Vice President
Tax withholdingCommon Stock 537 $145.83 $78,310.71
Disclosure

SEC source: 0001127602-22-008997 · form4.xml · nonDerivative · entry 2

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,097.4822

Read SEC document
March 09, 2022 Filed Mar 11, 2022 20:41 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionCommon Stock 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-22-008997 · form4.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,634.4822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.